vimarsana.com

Latest Breaking News On - Lilly spain - Page 1 : vimarsana.com

SURPASS-5: Tirzepatide lowers HbA1c in adults with type 2 diabetes on insulin glargine

Adults with type 2 diabetes assigned tirzepatide alongside insulin glargine had greater reductions in HbA1c and body weight compared with placebo, according to data from the SURPASS trial program. In findings from the SURPASS-5 randomized clinical trial published in JAMA, participants assigned 5 mg, 10 mg or 15 mg tirzepatide (Eli Lilly), a glucose-dependent insulinotropic polypeptide

Novel Tirzepatide Wins as Insulin Glargine Add-On

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.